We’re keeping our fingers crossed for a new treatment for X-linked hypophosphatemia (XLH) that is being considered by the Pharmaceutical Benefits Advisory Committee (PBAC) in March 2022. The PBAC has opened its consumer comments portal so we’re encouraging all members of our XLH community to share their story. Fingers crossed!
The Standing Committee on Health, Aged Care and Sport has recently tabled its report in the Australian Parliament – The New Frontier: Delivering better health to all Australians. XLH Australia is a strong advocate for the patient voice and we are working toward better access to new medications for all Australians. We were delighted to provide a witness statement as
Each year on 3 December we celebrate International Day of People with Disability (IDPwD). IDPwD is a United Nations observed day aimed at increasing public awareness, understanding and acceptance of people with disability. It’s also a time to celebrate the contributions and achievements of people with disability and promote inclusion within the community including workplaces. XLH is a debilitating rare
Accessing your best care: To celebrate International XLH Day on 23 October 2021, the International XLH Alliance delivered a campaign focusing on what it means to access your best care. The campaign shared patience stories from across the world and shared some tips for members of the XLH community to ensure they are receiving the best care possible for them
XLH Awareness Day was 23 June 2021. This year, we were fortunate enough to be able to host a morning tea with the Parliamentary Friends of Medicines in Canberra. Dr Tony Lafferty and Dr Peter Simm provided an overview of the clinical diagnosis of XLH and the burden of the disease. In addition, our President, Sandy, shared her story while